JKHY (JKHY)

$11.3B
Market Cap
22.4
P/E Ratio
0.73
Beta
1.50%
Dividend Yield
Piotroski 7/9Altman Z 10.5 SafeBeneish M -2.77 Clean

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 10.5 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of JKHY is robust, evidenced by an ROIC-WACC spread that suggests strong value creation relative to the cost of equity. The 21.4% return on equity is primarily driven by exceptional profitability rather than leverage or asset velocity; specifically, a net margin of 19.2% and gross margin expansion to 42.7% indicate durable pricing power and operational control over costs. This high-quality earnings profile is further corroborated by a Piotroski F-Score of 7/9 and a Beneish M-Score of -2.77, signaling strong financial health with minimal likelihood of earnings manipulation despite moderate revenue growth of 7.2% year-over-year.

Valuation metrics present a nuanced picture where the current P/E multiple of 22.4x sits at a premium relative to typical software sector averages but remains justified by the company's superior margin expansion and low leverage profile, as indicated by an equity multiplier of only 1.43x. While the DuPont decomposition reveals that asset turnover is constrained at 0.78x, limiting total exposure growth compared to high-velocity peers, the DCF model implies a fair value of $132, suggesting the market may be pricing in conservative assumptions regarding future margin sustainment or growth acceleration beyond the current 7.2% trajectory.

Insider flow data over the past 90 days remains neutral at zero dollars, offering no immediate signal of management conviction shifts to counterbalance the strong fundamental scores. Collectively, the risk-reward profile appears skewed toward stability given the low leverage and clean audit signals, yet investors must weigh whether the current valuation adequately compensates for the sub-linear revenue growth rate against peers with higher asset turnover ratios.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$161$118$93
3%$189$132$101
4%$230$150$111

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $132 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
10.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.77
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

42.7%
Gross Margin
19.2%
Net Margin
18.8%
ROIC
+7.2%
Revenue Growth (YoY)
+19.4%
Earnings Growth (YoY)
410.3M
Free Cash Flow
40%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

19.2%
Net Profit Margin
NI ÷ Revenue
×
0.78x
Asset Turnover
Revenue ÷ Assets
×
1.43x
Equity Multiplier
Assets ÷ Equity
=
21.4%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.43x
Debt / Equity
1.27x
Current Ratio
57.1x
Interest Coverage
3.66%
FCF Yield
801.2M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.33
Act: $1.45
+8.7%
Q3
✓ Beat
Est: $1.50
Act: $1.56
+4.1%
Q2
✓ Beat
Est: $1.65
Act: $1.86
+12.8%
Q1
✓ Beat
Est: $1.42
Act: $1.66
+17.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

22.5
Forward P/E
PEG Ratio
5.12
Price/Book
958113
Avg Volume
$193.39
52W High
$144.12
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.7B
Tracked Passive Exposure
8
ETFs Holding JKHY
0.04%
Avg Weight in ETFs
$4.0T
Total ETF AUM

When investors buy or sell ETFs like MOAT or SDY, the fund manager is mechanically forced to buy or sell JKHY shares regardless of JKHY's individual fundamentals. We estimate $1.7B of passive capital is structurally linked to JKHY through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in JKHY to visualize passive redemption contagion across ETFs and collateral stocks.

JKHY Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
JKHYEpicenterVOOETFIVVETFSPYETFHIILow RiskABNBLow RiskELMed RiskBMYMed RiskUPSMed Risk
JKHY Price Drop (%)0

If JKHY (JKHY) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Huntington Ingalls Industries Inc (HII) as the most exposed collateral stock, sharing 1 ETFs with JKHY. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 30 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

JKHY Ownership Dynamics

Ticker
JKHY

Float lock-up computed from 30 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

JKHY Capital Efficiency

How efficiently does JKHY convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$410M
EBITDA
$801M
FCF Conversion
51%
Reinvestment Rate
49%
51% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

JKHY converts 51% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13605$144.73$87,561.65
2026-04-2711$151.15$1,662.65
2026-04-20162$154.06$24,957.72
2026-04-08256$158.32$40,529.92
2026-04-0722$158.10$3,478.2
2026-04-01169$158.04$26,708.76
2026-03-257$158.87$1,112.09
2026-03-192,924$165.15$482,898.6
2026-03-172,134$167.35$357,124.9
2026-03-1617$168.77$2,869.09
2026-03-121,509$167.01$252,018.09
2026-03-095,364$171.83$921,696.12
2026-03-0693$167.05$15,535.65
2026-03-0593$168.43$15,663.99
2026-03-0245$162.46$7,310.7
2026-02-2775$161.08$12,081
2026-02-12120,734$165.65$20.0M
2026-02-0659,266$176.96$10.5M
2026-02-0523$173.78$3,996.94
2026-02-02236$179.21$42,293.56
2026-01-2172,356$186.85$13.5M
2026-01-073,586$185.56$665,418.16
2026-01-053,068$178.35$547,177.8
2026-01-021,575$182.48$287,406
2025-12-312,812$184.55$518,954.6
2025-12-269,105$185.18$1.7M
2025-12-2220,015$184.50$3.7M
2025-12-1212,876$187.18$2.4M
2025-12-091$180.99$180.99
2025-12-0816$181.71$2,907.36

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare JKHY to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.